Dtsch Med Wochenschr 2007; 132(9): 437-441
DOI: 10.1055/s-2007-970354
Übersicht | Review article
Telemedizin, Gynäkologie
© Georg Thieme Verlag KG Stuttgart · New York

Telemetrische Blutdruck- und Gewichtskontrolle in der Schwangerschaft

Telemetric monitoring of blood pressure and body weight during pregnancyM. Middeke1 , F. Köhler2 , T. Schweizer3 , J. W. Dudenhausen4
  • 1Blutdruckinstitut München
  • 2Charité - Universitätsmedizin Berlin, Medizinische Klinik, Schwerpunkt Kardiologie, Angiologie
  • 3Actimon GmbH, München
  • 4Klinik für Geburtsmedizin, Charité, Universitätsmedizin Berlin
Further Information

Publication History

eingereicht: 11.9.2006

akzeptiert: 15.2.2007

Publication Date:
21 February 2007 (online)

Literatur

  • 1 American College of Obstetricians and Gynecologists .Hypertension in pregnancy. ACOG 1996
  • 2 Anon. Report on confidential enquiries into maternal deaths in the United Kingdom 1994 - 1996. London: Stationery Office 1998
  • 3 Baeten J M, Bukusi E A, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women.  Am J Public Health. 2001;  91 436-440
  • 4 Barton J R, Istwan N B, Rhea D. et al . Cost-savings analysis of an outpatient management program for women with pregnanacy-related hypertensive conditions.  Disease Management. 2006;  9 236-241
  • 5 Biswas A, Choolani M A, Anandakumar C, Arulkumaran S. Ambulatory blood pressure monitoring in pregnancy induced hypertension.  Acta Obstet Gynecol Scand. 1997;  76 829-833
  • 6 Brown M A, Robinson A, Bowyer L, Buddle M L, Martin A, Hargood J L. et al . Ambulatory blood pressure monitoring in pregnancy: what is normal?.  Am J Obstet Gynecol. 1998;  178 836-842
  • 7 Butters L, Kennedy S, Rubin P C. Atenolol in essential hypertension during pregnancy.  BMJ. 1990;  301 587-589
  • 8 Cedergren M I. Maternal morbid obesity and the risk of adverse pregnancy outcome.  Obstet Gynecol. 2004;  103 219-224
  • 9 Chappell L C, Seed P T, Briley A L. et al . Effects of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomizied trial.  Lancet. 1999;  354 810-816
  • 10 Clapp J F, Seaward B L, Sleamaker R H, Hiser J. Maternal physiologic adaptations to early human pregnancy.  Am J Obstet Gynecol. 1988;  159 1456-1460
  • 11 Cnattingius S, Bergstrom R, Lipworth L, Kramer M S. Pregnancy weight and the risk of adverse pregnancy outcomes.  N Engl J Med. 1998;  338 147-152
  • 12 Cogswell M E, Yip R. The influence of fetal and maternal factors on the distribution of birthweight.  Sem Perinatol. 1995;  19 222-240
  • 13 Cooper W O, Hernandez-Diaz S, Arbogast P. et al . Major congenital malformations after first-trimester exposure to ACE inhibitors.  N Engl J Med. 2006;  354 2443-2451
  • 14 von Dadelszen P, Ornstein M P, Bull S P. et al . Fall in mean arterial pressure and fetal growth restriction in pregnanacy hypertension: a meta-analysis.  Lancet. 2000;  355 87-92
  • 15 Davey D A, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy.  Am J Obstet Gynecol. 1988;  158 892-898
  • 16 Davison J M, Homuth V, Jeyabalan A. et al . New aspects in the pathophysiology of preeclampsia.  J Am Soc Nephrol. 2004;  15 2440-2448
  • 17 Deutsche Hochdruckliga . Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie - Hochdruck in der Schwangerschaft und Stillperiode.  Dtsch Med Wochenschr. 2001;  126 225-229
  • 18 De Swiet M. Blood pressure measurement in pregnancy.  Br J Obstet Gynaecol. 1991;  98 239-240
  • 19 De Swiet M, Shennan A. Blood pressure measurement in pregnancy.  Br J Obstet Gynaecol. 1996;  103 862-863
  • 20 Easterling T R, Brateng D, Schmucker B, Brown Z, Millard S P. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.  Obstet Gynecol. 1999;  93 725-733
  • 21 Friedman E A, Neff R K. Hypertension-hypotension in pregnancy: Correlation with fetal outcome.  JAMA. 1978;  239 2249-2251
  • 22 Grunberger W, Leodolter S, Parschalk O. Maternal hypotension: fetal outcome in treated and untreated cases.  Gynecologic Obstetric Invest. 1979;  10 32-38
  • 23 Halligan A, O’Brien E, O’Malley K, Mee F, Atkins N, Conroy R. et al . Twenty-four-hour ambulatory blood pressure measurement in a primigravid population.  J Hypertens. 1993;  11 869-873
  • 24 Helewa M E, Burrows R F, Smith J, Williams K, Brain P, Rabkin S W. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.  CMAJ. 1997;  157 715-725
  • 25 Johenning A R, Barron W M. Indirect blood pressure measurement in pregnancy: Korotkoff phase 4 versus phase 5.  Am J Obstet Gynecol. 1992;  167 577-580
  • 26 Lenfant C. Working group report on high blood pressure in pregnancy.  J Clin Hypertens (Greenwich). 2001;  3 75-88
  • 27 Lindheimer M C, Katz A I. Gestation in women with kidney disease: prognosis and management.  Clin Obstet Gynaecol. 1987;  1 921-937
  • 28 Magee L A, Ornstein M P, von Dadelszen P. Management of hypertension in pregnancy.  BMJ. 1999;  318 1332-1336
  • 29 MacGillivray I, Rose G A, Rowe B. Blood pressure survey in pregnancy.  Clin Sci. 1969;  37 395-407
  • 30 Margulies M, Voto L S, Fescina R, Lastra L, Lapidus A M, Schwarcz R. Arterial blood pressure standards during normal pregnancy and their relation with mother-fetus variables.  Am J Obstet Gynecol. 1987;  156 1105-1109
  • 31 Middeke M. Arterielle Hypertonie. Georg Thieme Verlag, Stuttgart New York 2005
  • 32 NIH publication No. 00 - 3029, originally printed 1990, revised July 2000. National High Blood Pressure Education Program - Working Group Report on High Blood Pressure in Pregnancy 2000
  • 33 Ng P H, Walters W A. The effects of chronic maternal hypotension during pregnancy.  Aust NZ J Obstet Gynaecol. 1992;  32 14-16
  • 34 Owens P E, Lyons S P, O’Brien E T. Arterial hypotension: prevalence of low blood pressure in the general population using ambulatory blood pressure monitoring.  J Hum Hypertens. 2000;  14 243-247
  • 35 Page E W, Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy.  Am J Obstet Gynecol. 1976;  125 740-746
  • 36 Perry I J, Wilkinson L S, Shinton R A, Beevers D G. Conflicting views on the measurement of blood pressure in pregnancy.  Br J Obstet Gynaecol. 1991;  98 241-243
  • 37 Pryde P G, Sedman A B, Nugent C E. Angiotensin-converting enzyme inhibitor fetopathy.  J Am Soc Nephrol. 1993;  3 1575-1582
  • 38 Qasqas S A, McPherson C, Frishman W H, Elkayam U. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation.  Cardiol Rev. 2004;  12 201-221
  • 39 Rath W. Hypertensive Schwangerschaftserkrankungen.  Der Gynäkologe. 1999;  32 432-442
  • 40 Rath W. Das HELLP-Syndrom. Stuttgart, Wiss. Verlagsgesellschaft In: Schwangerschafthochdruck (Heilmann L, Rath W (Hrsgb.) 2002: 236-255
  • 41 Redman C WG, Beilin L J, Bonnar J. Variability in normal and abnormal pregnancy. In: Lindheimer MD, Katz AI, Zuspan FP (eds.): Hypertension in Pregnancy Wiley, New York, 1976: 53
  • 42 Redman C WG, Beilin L J, Bonnar J, Ounsted M K. Fetal outcome in trial of antihypertensive treatment in pregnancy.  Lancet. 1976;  2 753-756
  • 43 Redman C WG, Jefferies M. Revised definition of pre-eclampsia.  Lancet. 1988;  1 809-812
  • 44 Reiss R E, O’Shaughnessy R W, Quilligan T J, Zuspan F P. Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies.  Am J Obstet Gynecol. 1987;  156 894-898
  • 45 Roberts J M, Cooper D W. Pathogenesis and genetics of pre-eclampsia.  Lancet. 2001;  357 53
  • 46 Rosenberg T J, Garbers S, Chavkin W, Chiasson M A. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population.  Obstet Gynecol. 2003;  102 1022-1027
  • 47 Saji H, Yamamanka M, Hagiwara A, Ijiri R. Losartan and fetal toxic effects.  Lancet. 2001;  357 363
  • 48 Sebire N J, Jolly M, Harris J P. et al . Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London.  Int J Obes Relat Metab Disord. 2001;  25 1175-1182
  • 49 Shennan A, Gupta M, Halligan A, Taylor D J, de Swiet M. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry.  Lancet. 1996;  347 139-142
  • 50 Sibai B M, Abdella T N, Anderson G D. Pregnancy outcome in 211 patients with mild chronic hypertension.  Obstet Gynecol. 1983;  61 571-576
  • 51 Sibai B M, Dekker G, Kupermin C. Preeclampsia.  Lancet. 2005;  365 785-799
  • 52 Steer P J. The definition of pre-eclampsia.  Br J Obstet Gynaecol. 1999;  106 753-755
  • 53 Steer P J. et al . Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study.  Br Med J. 2004;  329 1312-1314
  • 54 Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study.  Lancet. 2006;  368 1164-1170
  • 55 Weiss J L, Malone F D, Emig D. et al . Obesity, obstetric complications and cesarean delivery rate - a population-based screening study.  Am J Obstet Gynecol. 2004;  190 1091-1097

Prof. Dr. med. Martin Middeke

Blutdruckinstitut München

Osterwaldstraße 69

80805 München

Phone: 0049/89/36103947

Fax: 0049/89/36104026

URL: http://www.blutdruckinstitut.de

    >